Clinical Pharmacokinetics

, Volume 36, Issue 5, pp 309–313 | Cite as

Interactions Between Oral Contraceptives and Antifungals/Antibacterials

Is Contraceptive Failure the Result?
  • Edith Weisberg
Current Opinion


The effectiveness of oral contraceptives may be impaired by concomitant treatment with antimicrobials. This may occur because of reductions in plasma concentrations of ethinylestradiol by the induction of hepatic metabolism, as for rifampicin (rifampin) and possibly griseofulvin, or in a small percentage of women because of interference with enterohepatic recirculation.

There are no scientific data to support the anecdotal evidence that the concomitant use of combined oral contraceptives and antimicrobials reduces contraceptive efficacy in the majority of women. It has been postulated that there is a subset of women in whom the enterohepatic recirculation of ethinylestradiol plays an important role. In these women the action of an antimicrobial may reduce the efficacy of oral contraceptives by interfering with this mechanism. Studies that have quantitatively examined these effects may have failed to include women from this subset because of the small numbers involved in the studies. On the other hand, there are no good prospective studies comparing contraceptive failure rates between compliant women who use combined oral contraceptives with and without antimicrobials.

All women using combined oral contraceptives should be informed of the very low level of risk of interactions with antimicrobials (probably about 1%) and that it is not possible to identify who may be at risk. Women concerned about this low level of risk should be given information about the use of barrier methods or avoidance of intercourse during the first 7 days of concomitant antimicrobial therapy and for 7 subsequent days. Women who have had previous contraceptive failures or developed breakthrough bleeding during concomitant antimicrobial use should be strongly advised to follow these precautions, as they may be part of the subset of women at higher risk of contraceptive failure.


Adis International Limited Oral Contraceptive Itraconazole Roxithromycin Griseofulvin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Helms SF, Bredle DI, Zajic J, et al. Oral contraceptive failure rates and oral antibiotics. J Am Acad Dermatol 1997 May; 36 (5 Pt 1): 705–10.PubMedCrossRefGoogle Scholar
  2. 2.
    Back DJ, Orme MLE. Pharmacokinetic drug interactions with oral contraceptives. Clin Pharmacokinet. 1990; 6: 472–84.CrossRefGoogle Scholar
  3. 3.
    Goldzieher JW, Brody SA. Pharmacokinetics of ethinyl estradiol and mestranol. Am J Obstet Gynaecol. 1990; 163: 2114–9.Google Scholar
  4. 4.
    Back DJ, Breckenridge AM, Crawford FE, et al. An investigation of the pharmacokinetics of ethinylestradiol in women using radioimmunoassay. Contraception. 1979; 20: 263–73.PubMedCrossRefGoogle Scholar
  5. 5.
    Guengerich PH. Inhibition of oral contraceptive steroid-metabolizing enzymes by steroids and drugs. Am J Obstet Gynaecol 1990; 163 (6 Pt 2): 2159–63.Google Scholar
  6. 6.
    Orme MLE, Back DI. Factors affecting the enterohepatic circulation of oral contraceptive steroids. Am J Obstet Gynaecol. 1990; 163: 2146–52.Google Scholar
  7. 7.
    Fotherby K. Interactions with oral contraceptives. Am J Obstet Gynaecol. 1990; 163: 2153–9.Google Scholar
  8. 8.
    Shenfield GM. Oral contraceptives: are drug interactions of clinical significance? Drug Saf 1993; 9(1): 21–37.PubMedCrossRefGoogle Scholar
  9. 9.
    Reimers D, Jezek A. Rifampicin und andere antituberkulostatika bei gleichzeitiger oraler kontrazeption. Praxis Klinik Pneumol. 1981; 25: 255–62.Google Scholar
  10. 10.
    Orme MLE, Back DJ, Breckenridge AM. Clinical pharmacokinetics of oral contraceptive steroids. Clin Pharmacol. 1983; 8: 95–136.CrossRefGoogle Scholar
  11. 11.
    Van Dijke CPH, Weber JCR. Interaction between oral contraceptives and griseofulvin. BMJ. 1984; 288: 1125–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Pillans PI, Sparrow MJ. Pregnancy associated with a combined oral contraceptive and itraconazole. NZ Med J. 1993; 208: 408.Google Scholar
  13. 13.
    van Puijenbroek EP, Feenstra J, Meyboom RH. Pill cycle disturbance in simultaneous use of itraconazole and oral contraceptives. Ned Tijdschr Geneeskd. 1998; 142: 146–9.PubMedGoogle Scholar
  14. 14.
    Stockley IH. Drug interactions. Oxford: Blackwell Science, 1994.Google Scholar
  15. 15.
    Back DJ, Tija JF. Azoles and allylamines: the clinical implications of interactions with cytochrome P-450 enzymes. J Dermatol Treat. 1990; 1: 11–3.CrossRefGoogle Scholar
  16. 16.
    Sinofsky FE, Pasquale SA. The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives. Am J Obstet Gynecol. 1998; 178: 300–4.PubMedCrossRefGoogle Scholar
  17. 17.
    Bacon JF, Shenfield GM. Pregnancy attributable to interaction between tetracycline and oral contraceptives. BMJ 1980 Feb 2; 280 (6210): 293.PubMedCrossRefGoogle Scholar
  18. 18.
    Bainton R. Interaction between antibiotic therapy and contraceptive medication. Oral Surg. 1986; 61: 453–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Dossetor J. Drug interactions with oral contraceptives. BMJ. 1975; 4: 467–8.CrossRefGoogle Scholar
  20. 20.
    De Sano EA, Hurley SC. Possible interactions of antihistamines and antibiotics with oral contraceptive effectiveness. Fertil Steril. 1982; 37: 853–4.Google Scholar
  21. 21.
    Back DI, Grimmer SFM, Orme MLE, et al. Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive drug interactions with anticonvulsants and antibiotics. J Clin Pharmacol. 1988; 25: 527–32.Google Scholar
  22. 22.
    Sparrow MJ. Pill method failure. NZ Med J. 1987; 100: 102–5.Google Scholar
  23. 23.
    Hughes BR, Canliffe WI. Interactions between the oral contraceptive pill and antibiotics [letter]. Br J Dermatol. 1990; 122: 717–8.PubMedCrossRefGoogle Scholar
  24. 24.
    London BM, Lookingbill DP. Frequency of pregnancy in acne patients taking oral contraceptives. Arch Dermatol. 1994; 130: 392–3.PubMedCrossRefGoogle Scholar
  25. 25.
    Friedman CL, Huneke AL, Kim MH, et al. The effect of ampicillin on oral contraceptive effectiveness. Obstet Gynaecol. 1980; 55: 33–7.Google Scholar
  26. 26.
    Murphy AA, Zakur HA, Charache P. The effect of tetracycline on levels of oral contraceptives. Am J Obstet Gynaecol. 1991; 164: 28–33.Google Scholar
  27. 27.
    Back DJ, Breckenridge AM, Maclver M, et al. The effects of ampicillin on oral contraceptive steroids in women. Br J Clin Pharmacol 1982 Jul; 14: 43–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Grimmer SFM, Allen WL, Back DJ, et al. The effective of cotrimoxazole on oral contraceptive steroids in women. Contraception. 1983; 28: 53–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Meyer B, Müller F, Wessels P, et al. A model to detect interactions between roxithromycin and oral contraceptives. Clin Pharmacol Ther. 1990; 47: 671–4.PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1999

Authors and Affiliations

  1. 1.Sydney Centre for Reproductive Health ResearchFamily Planning NSWAshfieldAustralia
  2. 2.Department of Obstetrics and GynaecologyUniversity of SydneySydneyAustralia

Personalised recommendations